Stock listing

NASDAQ:TDACU Translational Development Acquisition Corp. Stock

US listing (NASDAQ) of Translational Development Acquisition Corp. · home listing NASDAQ:TDAC

Follow Translational Development Acquisition Corp. into a list and get an email when it puts out news.

Share price · NASDAQ:TDACU

$11.48 USD

Close on Oct 22, 2026

Day range: $11.48 – $11.48 USDOct 22, 2026

Prices by listing

Listing	Last	Change	Volume	Open	High	Low	Previous close	Price from
NASDAQ:TDAC · Home	$10.83 USD	+0.01 (+0.1%)	75,350	$10.82	$10.84	$10.80	$10.82	Close on Nov 2, 2026
NASDAQ:TDACU	$11.48 USD	—	—	$11.48	$11.48	$11.48	—	Close on Oct 22, 2026

Ticker: NASDAQ:TDACU
Asset type: Fund
Sector: Financials
Industry: Shell companies & SPACs
Exchange: NASDAQ
Currency: USD

What changed lately

Latest news release · Jul 28, 2026
ProLogium and Translational Development Acquisition Corp. Announce $50 Million Committed Primary Capital Investment to Support Proposed Business Combination

Latest news

ProLogium and Translational Development Acquisition Corp. Announce $50 Million Committed Primary Capital Investment to Support Proposed Business Combination

Jul 28, 2026

TDAC reports 85% shareholder retention, $156.8M remaining in trust after extension vote

Jun 23, 2026

Battery maker ProLogium to list on Nasdaq in $3.8 billion SPAC deal

May 27, 2026

Translational Development Acquisition Corp. 1Q 2026: Net income $1.33M, EPS $0.06— 10-Q Summary

May 15, 2026

Translational Development Acquisition Corp. SEC 10-Q Report

Nov 14, 2025

Translational Development Acquisition Corp. Releases Q1 2025 10-Q Report

May 15, 2025

All Translational Development Acquisition Corp. news

Financings

Strategic investment of primary capital investment
Jul 28, 2026
Announced: US$50M · Cohen & Company Capital Markets +2
Dealers: Cohen & Company Capital Markets (lead), Credit Agricole Securities (USA) Inc., BTIG, LLC
Buyers: existing ProLogium shareholders ($50 million primary capital investment)
Insiders: Committed by a consortium of existing ProLogium shareholders, described as insider investor support
Use of proceeds: Scale up lithium ceramic battery production, build the Dunkirk, France gigafactory and expand into data centers, aerospace and robotics
Announced Jul 28, 2026

Read by 6ix AI from the company's releases

Translational Development Acquisition Corp. on 6ix

Sector: Financials
Industry: Shell companies & SPACs
News releases: 5 in the last 12 months · 6 in all · newest Jul 28, 2026 · oldest 2025

Where Translational Development Acquisition Corp. is listed

Listing	Exchange	Country	Currency
NASDAQ:TDAC · Home listing	NASDAQ	United States	USD
BOATS:TDAC	BOATS	United States	USD
NASDAQ:TDACU · This page	NASDAQ	United States	USD

Log in to ask 6ix AI your own questions about Translational Development Acquisition Corp.